发明名称 |
Composition for suppressing expression of target gene |
摘要 |
An object of the present invention is to provide a composition for suppressing expression of a target gene, and the like. A composition comprising an RNA-encapsulated liposome, wherein the RNA contains a sequence consisting of 15 to 30 contiguous bases of a target gene mRNA (hereinafter, sequence X) and a base sequence (hereinafter, complementary sequence X′) complementary to the sequence X, 1 to 90% of all sugars binding to the bases of the sequence X and the complementary sequence X′ being ribose substituted by a modifying group at 2′ position, and the lipid particle being capable of reaching a tissue or an organ containing an expression site of the target gene is provide. |
申请公布号 |
US9061042(B2) |
申请公布日期 |
2015.06.23 |
申请号 |
US201113017562 |
申请日期 |
2011.01.31 |
申请人 |
Kyowa Hakko Kirin Co., Ltd. |
发明人 |
Yagi Nobuhiro;Enokizono Junichi |
分类号 |
C12N15/11;A61K31/7105;A61K9/00;A61K9/127;A61K31/712;A61K31/713;C12N15/113 |
主分类号 |
C12N15/11 |
代理机构 |
Wenderoth, Lind & Ponack, L.L.P. |
代理人 |
Wenderoth, Lind & Ponack, L.L.P. |
主权项 |
1. A method for improving blood RNA concentration after a second administration to a mammal of a composition comprising a RNA-encapsulated lipid particle comprising a polyethylene glycolated lipid, a polyethylene glycol sorbitan fatty acid ester or a polyethylene glycol fatty acid ester, wherein the RNA comprises a sequence X consisting of 15 to 30 contiguous bases of a target gene mRNA and a base sequence X′ complementary to the sequence X, comprising twice administering to a mammal the composition
wherein 10 to 75% of all sugars in the RNA binding to the bases of the sequence X and the base sequence X′ are ribose substituted by a modifying group selected from the group consisting of 2′-fluoro, 2′-O-methyl, 2′-O-ethyl. |
地址 |
Tokyo JP |